Abstract:Background Phosphoglycerate kinase 1 (PGK1) plays a crucial role in the glycolytic pathway and its overexpression has a negative impact on tumor development and prognosis. Resveratrol, a natural polyphenolic compound, has gained significant attention in recent years due to its anti-inflammatory, antioxidant, and anti-tumor properties. However, the mechanism by which resveratrol inhibits breast cancer growth, invasion, and metastasis through the PGK1 glycolytic pathway is still not fully understood. Therefore, this study aimed to investigate the inhibitory effects of resveratrol on breast cancer cell proliferation and invasive migration, as well as its ability to promote apoptosis in vitro. Additionally, the study examined the inhibitory effects of resveratrol on the growth of mouse breast cancer graft tumors in vivo. Methods We analyzed the expression levels of glycolytic enzymes in different breast tissues and their correlation with the prognosis of breast cancer patients through GEPIA and The Human Protein Atlas database. Wound healing assay, Transwell migration and invasion assay were used to study the effect of resveratrol on the biological functions of breast cancer. RT-qPCR and Western blot methods were used to explore the potential molecular mechanism of resveratrol inhibiting the development of breast cancer through the PGK1 glycolysis pathway. In vivo experiments explore the biological mechanisms behind PGK1-mediated breast cancer proliferation and invasion. Results High expression of PGK1 is significantly associated with poor prognosis in breast cancer patients, and resveratrol induces breast cancer cell apoptosis in a dose-dependent manner, inhibiting PK, PGK1, LDH enzyme activity and ATP content. Resveratrol inhibits PGK1 expression and its related c-Myc/PI3K/AKT signaling pathway. Western blot experiments show that resveratrol affects the biological functions of breast cancer by inhibiting PCNA, MMP2 and MMP9 proteins and activating BAX/Bcl-2 and Caspase3/7 proteins. In addition, in vivo experiments show that resveratrol significantly inhibits the growth of transplanted tumors in breast cancer mice and inhibits breast cancer tumor proliferation, invasion and metastasis by downregulating PGK1 expression. Conclusion Resveratrol demonstrates inhibitory effects on breast cancer cell proliferation, invasive and migration, as well as induction of apoptosis in vitro. It also inhibits the growth of mouse breast cancer transplantation tumors in vivo and exhibits oncostatic effects both in vitro and in vivo. Moreover, resveratrol reduces the expression of PGK1 in breast cancer BT-549 cells by regulating the transcription factors c-Myc. This regulation leads to the blockage of cellular glycolysis pathways, ultimately inhibiting the malignant biological behavior of breast cancer cells.

Resveratrol Inhibits Erk1/2-Mediated Adhesion Of Cancer Cells Via Activating Pp2a-Pten Signaling Network

Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.

Resveratrol Inhibits Hyperglycemia-Driven ROS-induced Invasion and Migration of Pancreatic Cancer Cells Via Suppression of the ERK and P38 MAPK Signaling Pathways.

Resveratrol Suppresses the Epithelial-to-mesenchymal Transition in PC-3 Cells by Down-Regulating the PI3K/AKT Signaling Pathway

Resveratrol Inhibits EGF-induced Invasion of Human Lung Adenocarcinoma A549 Cells

Resveratrol Suppresses Colon Cancer Growth by Targeting the AKT/STAT3 Signaling Pathway.

Beta-arrestin 2 Modulates Resveratrol-Induced Apoptosis and Regulation of Akt/GSK3β Pathways

Correction To: Resveratrol Inhibits the Expression of RYR2 and is a Potential Treatment for Pancreatic Cancer

Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9

Resveratrol inhibits pancreatic cancer proliferation and metastasis by depleting senescent tumor-associated fibroblasts

Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity

Resveratrol Inhibits VEGF Expression of Human Hepatocellular Carcinoma Cells Through a NF-kappa B-mediated Mechanism.

Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling.

Resveratrol Inhibited the Metastatic Behaviors of Cisplatin-Resistant Human Oral Cancer Cells Via Phosphorylation of ERK/p-38 and Suppression of MMP-2/9.

Resveratrol Inhibits Invasion and Metastasis of Hepatocellular Carcinoma Cells

Effects of Resveratrol on Mouse B16 Melanoma Cell Proliferation through the SHCBP1-ERK1/2 Signaling Pathway

Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line

Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism

[Corrigendum] Resveratrol Inhibits the Invasion and Metastasis of Colon Cancer Through Reversal of Epithelial‑mesenchymal Transition Via the AKT/GSK‑3β/Snail Signaling Pathway.

Mechanism of Resveratrol Affecting Biological Functions of Breast Cancer Through Glycolysis Pathway

Resveratrol suppresses the invasion and migration of human gastric cancer cells via inhibition of MALAT1-mediated epithelial-to-mesenchymal transition